MSCA DN—INNOVARTBRAIN：推进胶质母细胞瘤（GBM）靶向α疗法（TAT）的博士岗位

MSCA DN- INNOVARTBRAIN: PHD position in advancing targeted alpha therapy (TAT) for Glioblastoma (GBM)

Université d'AngersANGERS, France

临床神经科学与精神病学分子与细胞神经科学

最近核实: 2026-10-08T10:32:38+00:00资料快照: 2026-10-12

机会简介

MSCA DN- INNOVARTBRAIN: PHD position in advancing targeted alpha therapy (TAT) for Glioblastoma (GBM)

申请要求

Master Degree or equivalent | We are looking for a highly motivated researcher with a Master’s degree in neuroscience, neuro-oncology, cancer biology, molecular biology, biomedical sciences, radiopharmacy, or a related field.

资助与薪酬

已核实来源中未注明资助情况。

资助条件

In accordance with the MSCA mobility rule, applicants must not have resided or carried out their main activity (e.g. | work or studies) in France for more than 12 months during the 36 months immediately preceding the recruitment, which is expected to take place in January or February 2027. | your periods of residence according to the MSCA mobility rule

薪酬: A salary in line with the guidelines of the MSCA-DN Programme including the monthly Living allowance based on France rate (4735,81 EUR), the monthly Mobility allowance (710 EUR) and, if applicable, the monthly Family allowance (660,00 EUR) and the monthly Special needs allowance (the exact amount may vary depending on specific circumstances). | These are gross amounts including compulsory deductions under national law, such as employer and employee social security contributions and direct taxes or the fixed-amount fellowship.

来源与核实信息

Source retrieval: 2026-10-08T10:32:38+00:00; open status evaluated: 2026-10-12T05:53:47.267469+00:00. Saved source evidence was reused where applicable.

来源 1 https://euraxess.ec.europa.eu/jobs/469152在新窗口打开

内容依据最近核实的公开信息整理，可能不包含全部申请条件。无法访问来源不代表职位关闭；申请前请向发布机构确认最新信息。